Teva Announces Approval And Shipment Of Generic Coreg Tablets (Medical News Today)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the company's Abbreviated New Drug Application (ANDA) to market its Generic version of GlaxoSmithKline's cardiovascular agent Coreg (Carvedilol) Tablets, 3.125 mg, 6.25 mg, 12.5 mg and 25 mg. Shipment of this product will begin immediately. [click link for ...

Signalife's Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor (PR Newswire via Yahoo! Finance)
Flanked by prominent Board members Robert Windom, M.D. and Steven Phillips, M.D., Signalife's Dr. Lowell Harmison - in conjunction with inventor Dr. Budimir Drakulic - have this day initiated the product launch of the revolutionary, one-of-a-kind, FDA- approved, ambulatory 12-lead ECG cardiovascular monitor.